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1. Introduction 
Fibromyalgia (FM) is a medically unexplained illness characterized by four quadrant pain 
lasting at least 3 months and accompanied by multiple areas of tenderness on palpation of 
the body using 4 kg force. FM occurs more often in women than men but is quite common in 
both sexes, occurring in approximately 3% of the population. Although sleep difficulties are 
not part of standard diagnostic criteria, insomnia complaints of poor and nonrestorative 
sleep are common and have been associated with intense of pain, fatigue, sleepiness, and 
cognitive difficulties in FM. 
FM frequently occurs in conjunction with chronic fatigue syndrome (CFS). CFS is a 
medically unexplained condition characterized by persistent or relapsing fatigue lasting at 
least 6 months, which substantially reduces normal activity. In addition to severe fatigue, 
one of the eight symptoms used for diagnosing CFS is “unrefreshing sleep”, and this sleep-
related problem is the most common complaint among CFS patients. 
Although, FM and CFS often have similar symptoms, including sleep-related complaints, 
differences between FM and CFS exist. In this chapter, we will review studies on sleep in 
FM and CFS patients in order to better understand differences between them. 
Polysomnographic studies have shown sleep problems in FM by using simple descriptive 
statistics, for instance, increased non-rapid eye movement (non-REM) Stage 1 sleep, reduced 
slow-wave (Stages 3 and 4) sleep, more arousals, prolonged sleep onset, reduced sleep 
efficiency, etc. Sleep problems in CFS shown by polysomnographic studies are quite similar 
to those in FM. However, we have shown that dynamic aspects of sleep, a new way of 
assessing sleep, are different between patients with CFS alone compared to those with 
CFS+FM. The probability of transition from rapid eye movement (REM) sleep to waking in 
CFS is greater than in healthy controls. Probabilities of transitions from waking, Stage 1 
sleep, and REM sleep to Stage 2 and those from slow-wave sleep to waking and Stage 1 
sleep are greater in FM+CFS than in healthy controls. 
Over the course of the many decades, sleep researchers have used simple descriptive 
statistics to characterize and summarize sleep architecture. While this methodology has 
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been extremely useful in defining the abnormalities that currently constitute sleep 
pathology, this approach does not explain specific patient complaints of disturbed and 
unrefreshing sleep. However, a dynamic analysis complements the classical approach by 
allowing an analysis of transition dynamics between sleep stages and shows that FM and 
CFS may be different illnesses associated with different problems in sleep regulation. 
2. Sleep studies and FM 
2.1 Sleep and symptoms of FM 
Although sleep difficulties are not part of standard diagnostic criteria (Wolfe et al., 1990), 
insomnia complaints of poor and nonrestorative sleep are common in patients with FM. An 
early study shows that 65.7% of patients with FM reported nonrestorative sleep (White et 
al., 1999). Recently, two epidemiologic studies (Bigatti et al., 2008; Theadom et al., 2007) 
reported that more than 90% of patients with FM complain about sleep problems such as 
difficulty falling asleep, difficulty falling back to sleep after waking up during nocturnal 
sleep, and unrefreshing sleep. Sleep is also one of the domains which associate most 
strongly with the patients’ overall impression of improvement (Arnold et al., 2011). 
Data strongly suggest that FM-like symptoms develop following sleep disruption in healthy 
volunteers. Four studies in normal healthy controls (Lentz et al., 1999; Moldofsky et al., 
1975; Moldofsky & Scarisbrick, 1976; Onen et al., 2001) have reported increases in 
musculoskeletal pain and/or decreases in pain threshold after a period of sleep disruption 
or deprivation, while one study did not find this result (Older et al., 1998). Moldofsky’s 
group found that Stage 4 sleep deprivation was associated with increasing in tenderness, 
musculoskeletal symptoms, and mood disturbances (Moldofsky et al., 1975; Moldofsky & 
Scarisbrick, 1976). In addition, healthy volunteers with disrupted sleep produced 
experimentally by sound pulses every 2 minutes but with normal total sleep time had a 
decrease in day-time energy levels. Moreover, their ability to do complex auditory 
monitoring tasks was also impaired (Martin et al., 1996). These data indicate that partial 
sleep deprivation can produce the hallmark symptoms of FM – namely, musculoskeletal 
achiness, marked daytime fatigue, and cognitive problems. 
One study reported that sleep disturbances led to exacerbation of pain in patients with FM 
(Affleck et al., 1996). One recent study reported that negative mood (i.e., depression and 
anxiety), which are common among chronic pain patients or poor sleepers, almost fully 
mediated the relationship between sleep and pain in chronic pain patients (O'Brien et al., 
2010). Moderating impact of depressive symptoms on the relationship between sleep and 
pain was also reported in another study (O'Brien et al., 2011). 
2.2 Sleep disorders in patients with FM 
One group suggested that as many as 33% of individuals with FM had the restless leg 
syndrome (Viola-Saltzman et al., 2010). Another recent study (Gold et al., 2004) reported a 
high rate of sleep disturbed breathing in patients with FM (i.e., 96%). The prevalence of 
overweight women (Moldofsky, 2002) may contribute to sleep disturbed breathing, such as 
sleep apnea and inspiratory airflow limitation with arousals (Gold et al., 2004). However, 
one study found that patients with FM had the same frequency of sleep apnea as normal 
controls (Molony et al., 1986). Unpublished data from our laboratory finds rates of FM in 
patients with polysomnography-documented obstructive sleep apnea to be similar to those 
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found in the community. A genetic study found common genetic characteristics between 
FM and narcolepsy (Spitzer & Broadman, 2010). 
2.3 Sleep abnormality in patients with FM 
In contrast to studies on sleep pathology, a host of studies strongly suggest that the pattern 
of sleep is abnormal in many FM patients. The most consistent abnormality is significantly 
increased Stage 1 sleep compared to healthy controls (Anch et al., 1991; Cote & Moldofsky, 
1997; Drewes et al., 1994; Landis et al., 2004; Leventhal et al., 1995; Molony et al., 1986; 
Shaver et al., 1997). Sleep disturbance in patients with FM is obvious because 
polysomnographic studies have shown longer sleep latencies (Drewes et al., 1994; Horne & 
Shackell, 1991; Landis et al., 2004), more wakefulness (Drewes et al., 1994), reduced sleep 
efficiency (i.e., the proportion of time spent sleeping relative to the time available for 
sleeping) (Drewes et al., 1994; Landis et al., 2004), reduced Stage 2 sleep (Landis et al., 
2004), and reduced Stage 4 sleep (Anch et al., 1991; Lashley, 2003) in FM patients compared 
to healthy control subjects of similar age. Patients with FM awaken more easily (Perlis et al., 
1997) and compared to healthy controls have higher levels of physical activity during the 
night (Affleck et al., 1996; Korszun et al., 2002). 
Although sleep efficiency was comparable to that of controls, FM patients showed more 
arousals (Jennum et al., 1993; Molony et al., 1986) and Stage 1 sleep (Molony et al., 1986). 
Molony et al. reported that patients with FM had three times more microarousals (brief sleep 
interruptions lasting 5-19 seconds) per hour than did healthy controls (Molony et al., 1986). 
These results indicate that patients with FM have poor sleep quality with fragmented sleep. 
An alpha-EEG anomaly during non-REM sleep has been considered a biologic correlate of 
chronic pain and a possible basis of nonrestorative sleep complains in patients with FM 
(Branco et al., 1994; Moldofsky et al., 1975; Moldofsky & Scarisbrick, 1976; Moldofsky, 1989; 
Roizenblatt et al., 2001). The alpha-EEG anomaly is excessive alpha wave intrusion which 
has been interpreted as a heightened arousal state during non-REM sleep (Moldofsky, 1989; 
Scheuler et al., 1983). However, this has not been found consistently across studies (Horne & 
Shackell, 1991). Alpha-delta sleep is an abnormal sleep EEG rhythm characterized by alpha 
activity that is superimposed on delta waves of Stages 3 and 4 sleep (McNamara, 1993). 
Horne and Shackell found that the mean alpha activity in Stages 2, 3, and 4 sleep were 
greater for the patients with FM than in healthy controls (Horne & Shackell, 1991). Branco et 
al. studied alpha and delta activity and the alpha-delta ratio across sleep cycles in patients 
with FM and healthy controls (Branco et al., 1994). The alpha-delta sleep anomaly occurred 
in almost all patients who had fragmented sleep; this anomaly was not observed in any of 
the healthy controls. Perlis et al. found that the alpha-EEG sleep associated with perception 
of shallow sleep and an increased tendency to display arousal in response to external 
auditory stimuli (Perlis et al., 1997). 
Most studies on alpha-EEG anomaly in patients with FM have been based on visual and hence 
relatively subjective analysis of the EEG. Using spectral analysis, a quantitative measurement 
is provided not only for alpha component of EEG, but also for other existing frequency 
components. Drewes et al. examined spectral EEG patterns and found that patients with FM 
showed more power in the alpha (higher frequency) band and a decrease in the lower 
frequency bands in Stages 2, 3, and 4 sleep and all sleep cycles (Drewes et al., 1995). However, 
the alpha-EEG anomaly is not specific for patients with FM in that it also occurs in healthy 
individuals (Horne & Shackell, 1991; Scheuler et al., 1983; Shaver et al., 1997) and in patients 
with disorders such as rheumatoid arthritis and CFS (Moldofsky et al., 1983; 1988). 
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A task force of the American Sleep Disorders Association has defined a cortical arousal 
(American Sleep Disorders Association, 1992) as a return to alpha or fast frequency EEG 
activity, well differentiated from the background, lasting at least 3 seconds. Cortical 
microarousals are briefer arousals lasting at least 1.5 seconds (Martin et al., 1997). While the 
major focus of sleep researchers studying arousals has been on EEG measures, one group 
(Pitson & Stradling, 1998) suggested that non-EEG markers might be an important and even 
more reliable sign of arousals than cortical arousal as reflected by the EEG. For example, it is 
known that somatosensory and auditory stimulation during sleep can produce alterations in 
cardiac, respiratory, and somatic measures without overt EEG desynchronization (Carley et 
al., 1997; Halasz, 1993; Winkelman, 1999). These changes are thought to reflect activation of 
the brainstem or subcortical arousal system without affecting the cortex. Hence current 
thinking is that there are different levels of arousal responses generated from subcortical 
and cortical areas of the brain (Sforza et al., 2000, 2002). 
One study (Sforza et al., 2000) showed that bursts of K-complexes and delta waves, 
expressions of an activation of subcortical arousal system, represent a real arousal response 
inducing cardiac activation similar to that found during cortical arousals (microarousal and 
phases of transitory activity). We have investigated sleep microstructure in young healthy men 
with no sleep complaints (Togo et al., 2006). We found increases in delta wave power in both 
cortical and subcortical arousals relative to just before the onset of the arousals; increases in 
delta power might be an even better measure of arousals than alpha wave changes. 
Symptoms of unrefreshing sleep are reported to be greater when the cyclic alternating 
pattern (CAP, periodic appearance of delta waves and K-complexes) of EEG occupies a 
greater percent of sleep (Terzano & Parrino, 2000). Sforza et al. suggested that bursts of delta 
waves and K-complexes were expressions of subcortical arousals representing a real arousal 
response with tachycardia similar to that seen during cortical arousals (Sforza et al., 2000). 
Patients with FM have increased amounts of CAP – more so in the more severely 
symptomatic patients (Rizzi et al., 2004). 
3. Sleep studies and CFS 
3.1 Sleep disorders in patients with CFS 
One of the symptoms used for diagnosing CFS is unrefreshing sleep, and, in fact, this sleep-
related problem is the most common complaint among patients with severe medically 
unexplained fatigue (Unger et al., 2004). Partial sleep deprivation in healthy people can 
produce marked daytime fatigue (Martin et al., 1996), cognitive problems (Martin et al., 
1996), and musculoskeletal achiness (Lentz et al., 1999; Moldofsky & Scarisbrick, 1976; Onen 
et al., 2001), which are the hallmark symptoms of CFS. 
Several early studies suggested that as many as one-half of individuals with CFS have mild 
sleep apnea syndrome (five or more episodes per hour of apnea/hypopnea), periodic leg 
movements, or the restless leg syndrome (Buchwald et al., 1994; Krupp et al., 1993). Other 
studies with more stringent criteria for these disorders either did not find this result (Krupp 
et al., 1993; Le Bon et al., 2000; Sharpley et al., 1997; Togo et al., 2008). 
3.2 Sleep abnormality in patients with CFS 
Polysomnographic studies suggest that the sleep architecture is abnormal in CFS patients. 
The most consistent abnormality is significantly reduced sleep efficiency when compared to 
controls (Fischler et al., 1997; Krupp et al., 1993; Morriss et al., 1993; Sharpley et al., 1997); 
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the reported average values range from clearly abnormal (i.e., 76.5%) (Fischler et al., 1997) to 
those within the normal range (i.e., 90%) (Morriss et al., 1993). From one study providing 
data on individual patients’ sleep efficiencies, one can estimate that 75% of CFS patients 
have reduced sleep efficiences (Krupp et al., 1993). Sleep disturbance in these patients is 
obvious because they often show increases in time needed to fall asleep (Morriss et al., 1993; 
Sharpley et al., 1997) and multiple periods of awakenings or arousals (Fischler et al., 1997; 
Morriss et al., 1993; Sharpley et al., 1997). Decrease in total duration of Stage 4 sleep has also 
been reported (Fischler et al., 1997). 
We have recently reported the sleep architecture of a sample of female CFS patients during a 
fixed period of their menstrual cycle and after excluding patients with diagnosable sleep 
disorders and co-existing major depressive disorder to reduce patient pool heterogeneity 
(Togo et al., 2008). These patients differed significantly from matched controls in showing 
evidence of sleep disruption in the form of significantly reduced total sleep time, reduced 
sleep efficiency, and shorter bouts of sleep than healthy controls. In comparison with 
controls, sleep in CFS had little effect on either self-reported sleepiness or fatigue. And, 
interestingly, for patients only, ratings of sleepiness and fatigue correlated well with total 
sleep duration and efficiency. Dichotomizing the patients into a group that felt sleepier after 
a night's sleep than before sleep [a.m. sleepier] and a group that felt less sleepy after a 
night's sleep [a.m. less sleepy] reduced the variability of the sleep records considerably 
(Togo et al., 2008).  
Those patients reporting less sleepiness after a night's sleep had sleep structures similar to 
those for healthy controls except for a shorter total sleep time and a commensurate 
reduction in Stage 2 sleep; moreover, they reported their fatigue and pain to diminish 
following sleep. In contrast, patients in the a.m. sleepier group had the greatest 
abnormalities of sleep architecture, including poor sleep efficiency, longer sleep latency, and 
more disrupted sleep as manifested by a higher percentage of short-duration sleep runs, 
than either controls or patients in the a.m. less sleepy group. 
As the time since awakening from sleep increases, sleep latency decreases (Devoto et al., 
1999), and one early study of young adults reported an average sleep latency of 30 seconds 
after a night of sleep deprivation (Carskadon & Dement, 1979). We have determined latency 
to fall asleep for patients with CFS and healthy controls, previously habituated to sleeping 
in a sleep lab, after such a night of sleep deprivation in our laboratory (Nakamura et al., 
2010). Nine healthy subjects fell asleep within 5 minutes, however 3 subjects took longer – 
falling asleep within 9 minutes. The CFS patients as a group showed a significantly longer 
latency to fall asleep after sleep deprivation, but the study population fell out into two 
groups with the largest group of 10 patients falling asleep within 5 minutes. However, the 
remaining 5 patients remained awake for a longer period than any control, suggesting that 
they may have a disorder of arousal. Sleep latency following sleep deprivation correlated 
inversely with sleep efficiency on the normal sleep night for the patients with CFS. Our 
results indicate that some CFS patients may have a disorder of arousal which interferes with 
normal sleep and may, at least in part, be responsible for their disabling fatigue. 
3.3 Exercise and sleep in patients with CFS 
Exercise elevates core body temperature and increases total duration of slow-wave sleep in 
the night following exercise in healthy people (Horne & Staff, 1983). To our knowledge, only 
our study (Togo et al., 2010) has compared sleep in CFS patients before and after exercise. 
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Exertion is a particularly interesting thing to study in CFS because a disabling and 
characteristic feature of CFS patients is that even minimal exertion produces a dramatic 
worsening of symptoms (Komaroff & Buchwald, 1991). No such effect occurs in healthy 
controls and, in fact, some reports, although anecdotal, suggest that acute exercise can 
actually improve sleep (Youngstedt et al., 1997). 
We have used a standard cardiac-type stress test to probe effects of exertion on symptoms in 
CFS patients in other studies too. First we found that CFS patients reported more fatigue as 
much as four days after the exercise stress test (Sisto et al., 1996). Next, we used actigraphy 
to monitor activity before and after exercise and found that activity levels also fell significantly 
four days after the exercise stress test (Sisto et al., 1998). We recently replicated and extended 
this finding using real-time assessment techniques and demonstrated that CFS symptoms do 
worsen several days after maximal exercise but that neither mood nor cognitive function was 
affected (Yoshiuchi et al., 2007). We interpreted these changes in activity to support the patient 
complaint of worsening of symptoms induced by exercise or effort. 
We recently investigated the influence of an acute bout of exercise on polysomnography and 
self-reported measures of sleep (Togo et al., 2010). CFS patients as a group have disrupted 
sleep characterized by significantly poorer quality sleep than controls. However, the 
patients as a group showed evidence of improved sleep after exercise. The results were 
clearer after we used the same stratification strategy that we had used in our earlier work 
(Togo et al., 2008), that is, splitting subjects into those who were either sleepier or less sleepy 
after a night’s sleep. As expected, exercise improved the sleep quality of healthy controls 
who had reported decreased morning sleepiness after the baseline sleep night. Contrary to 
expectation, it had the same result in CFS patients with decreased morning sleepiness. 
However, patients who reported increased morning sleepiness showed no improvement in 
sleep disruption, but exercise did not exacerbate their sleep pathology. These patients also 
had the lowest average sleep efficiency of any of the groups studied. Because exercise did 
not produce a significant worsening of sleep morphology in CFS, the complaints of 
symptom worsening, which are reported to occur the next day after exertion, cannot be 
explained by disruption in sleep. After exercise, approximately half the patients actually 
sleep better than on their baseline study night, whereas the rest simply did not improve. 
4. Sleep dynamics 
4.1 Sleep dynamics in healthy humans 
Most sleep studies have been performed based upon sleep stage scoring according to the 
traditional standardized criteria established by Rechtschaffen and Kales (Rechtstchaffen & 
Kales, 1968). While this methodology has been extremely useful to describe sleep 
architecture, sleep stage analysis has been limited to simple descriptive statistics, such as 
total sleep time, sleep efficiency, the number of awakenings, latencies to sleep onset and 
REM sleep, and the total duration of each sleep stage. 
Recently, sleep dynamics, such as transition probabilities among sleep stages and duration 
distributions of each sleep stage, has been reported by some studies in which the importance 
of dynamical aspects of sleep has been pointed out (Comte et al., 2006; Kishi et al., 2008, in 
press; Lo et al., 2002). Yassouridis et al. (Yassouridis et al., 1999) studied survival time 
statistics of a particular sleep stage ended by other different sleep stages with their event 
history analysis, a modification of the Cox regression analysis of life-tables (Cox, 1972), by 
assuming an exponential decay of sleep stage durations, 
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 ( ) ~ tP t e   (1) 
where the P(t) is a probability distribution of durations t of a sleep stage and the τ is a 
constant. Lo et al. studied the dynamics of two-state asleep-awake transitions during sleep 
in humans, focusing on the duration distributions, and found entirely different behavior  
in the periods awake and asleep (Lo et al., 2002). Subsequently, they expanded their 
investigations in humans to other mammalian species, i.e., mice, rats, and cats (Lo et al., 
2004). Durations of awake during sleep exhibited a power-law distribution for all species, 
while durations of sleep episode followed exponential distributions. Comte et al. 
investigated the transition probabilities and duration distributions of three sleep stages 
(awake, non-REM, and REM sleep) in rats (Comte et al., 2006). Duration statistics of REM 
sleep in rats took a power-law probability distribution, 
 ( ) ~P t t

 (2) 
where the α is a constant, partially devaluing the exponential survival time analysis. Finding 
a power-law relation in REM sleep and waking durations rather than an exponential decay 
characteristic of random survival times (Lo et al., 2002, 2004) points to the presence of an 
underlying complex mechanism governing sleep stage transitions because power-law or 
heavy-tailed distributions of survival times are often observed in a variety of complex 
systems (Sethna et al., 2001; Sornette, 2004). 
We have recently investigated transition dynamics in humans for six sleep stages (awake, 
Stages 1, 2, 3, and 4 sleep, and REM sleep), the entire set of sleep states in humans (Kishi et 
al., 2008). Duration of slow-wave sleep follows a power-law probability distribution 
function, while the durations of Stage 1 sleep take an exponential function, those of Stage 2 
sleep obey a stretched exponential form characteristic of a multifactorial decay (Sornette, 
2004), and REM sleep durations follow an exponential function. We have also found a 
substantial number of REM to non-REM sleep transitions in humans, while this transition is 
reported to be virtually nonexistent in rats (Comte et al., 2006). These features likely reflect 
stage-specific neural activities (De Gennaro & Ferrara, 2003; Hobson et al., 1986; Koyama & 
Hayaishi, 1994; McCarley, 2007), and theories explaining different duration or survival time 
distributions (Sornette, 2004) might give deeper insights into the underlying mechanisms 
governing sleep stage regulations. 
4.2 Sleep dynamics in patients with FM and CFS 
FM and CFS share considerable overlapping symptoms, including sleep-related complaints. 
However, differences between FM and CFS have been reported, and research focusing on 
uncovering differences between these medically unexplained illnesses is helpful to understand 
them, rather than focusing on their similarities (Lange & Natelson, 2009). Polysomnographic 
studies have shown that sleep problems in FM and CFS are quite similar, for instance, 
increased Stage 1 sleep, reduced slow-wave sleep, more arousals, prolonged sleep onset, 
reduced sleep efficiency, and the alpha-EEG anomaly, as shown in the previous sections 
(Fischler et al., 1997; Moldofsky, 2008; Sharpley et al., 1997; Van Hoof et al., 2007). However, 
these observations are not consistent between studies for both FM and CFS, and there are even 
cases not showing any statistical differences in normal sleep parameters between healthy 
controls and FM or CFS patients (Afari & Buchwald, 2003; Chervin et al., 2009; Fischler, 1999; 
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Reeves et al., 2006). In our study (Togo et al., 2008), after excluding patients with diagnosable 
sleep disorders, such as sleep-disturbed breathing and leg movement disorders, patients with 
CFS plus FM had sleep architecture similar to those of patients with CFS alone. 
We have found robust differences in sleep dynamics between healthy controls and patients 
with CFS (Kishi et al., 2008). Although the duration distributions of each sleep stage are not 
different between healthy controls and patients with CFS, probabilities of transition from 
both Stage 1 sleep and REM sleep to awake are significantly greater in patients with CFS 
than healthy controls, indicating that the influence of factors interfering with the 
continuation of Stage 1 sleep and REM sleep may be different between healthy controls and 
CFS patients, while the fundamental mechanisms determining durations of each sleep stage 
are similar. CFS patients might not have a dysfunction in systems maintaining each sleep 
stage, but they may have a disturbed switching mechanism governing sleep stage 
transitions. Our data suggest that the major complaint of CFS patients of “unrefreshing 
sleep” may be derived from this sudden arousal from both Stage 1 sleep and REM sleep. 
One study (Burns et al., 2008) showed that sleep stage dynamics was different between 
patients with FM and healthy controls. Patients with FM showed a parameter that reflects 
shortened durations of Stage 2 sleep periods. Although shorter Stage 2 sleep durations did 
not predict daytime sleepiness, they did predict pain which is the main symptom in FM. 
Short Stage 2 sleep durations may associate with sleep fragmentation or pressure for 
recovery sleep. 
We have recently compered dynamical aspects of sleep, such as transitions probabilities 
between sleep stages between CFS alone and CFS+FM patients and found differences 
between them, although sleep architecture did not differ between the groups (Kishi et al., in 
press). CFS alone has greater probabilities of transitions from REM sleep to awake than 
healthy controls. This result could be interpreted as a lower sleep pressure in CFS alone. In 
contrast, CFS+FM has greater probabilities of transitions from waking, Stage 1 sleep, and 
REM sleep to Stage 2 sleep and from Stage 2 sleep to slow-wave sleep than healthy controls, 
suggesting the increased sleep pressure in CFS+FM. Transitions from waking and REM 
sleep to Stage 2 sleep are unusual transitions in healthy humans (Kishi et al., 2008). CFS+FM 
also has greater probabilities of transitions from slow-wave sleep to waking and Stage 1 
sleep, suggesting that this may be the specific sleep problem of CFS+FM. 
There are reports of decreased level of central serotonin in FM patients (Juhl, 1998; Neeck & 
Riedel, 1994). On the other hand, it has been observed that central serotonin responses are 
upregulated in CFS patients (Afari & Buchwald, 2003; Weaver et al., 2010). We have recently 
reported that the administration of central monoaminergic (serotonergic and dopaminergic) 
antagonist alters dynamical sleep stage transitions from Stage 2 sleep to slow-wave sleep; 
probability of transition from Stage 2 sleep to slow-wave sleep was significantly increased 
when central serotonergic and dopaminergic antagonist was administered (Kishi et al., 
2010). Such monoaminergic systems are closely related with pain modulation (Bannister et 
al., 2009). Thus, the imbalance of central monoaminergic (serotonergic) systems in FM 
patients would lead to abnormalities of pain modulations and sleep regulations. 
5. Conclusion 
Patients with FM and CFS often have sleep-related complaints. Polysomnographic studies 
have shown sleep problems in FM, i.e., increased Stage 1 sleep, reduced slow-wave sleep, 
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more arousals, prolonged sleep onset, reduced sleep efficiency, the alpha-EEG anomaly 
during sleep. Although these problems are also shown in patients with CFS, dynamic 
aspects of sleep show different patterns between FM and CFS patients. Patients with 
CFS+FM had greater probabilities of transitions from waking, Stage 1 sleep, and REM sleep 
to Stage 2 sleep and from Stage 2 sleep to slow-wave sleep than healthy controls, suggesting 
the increased sleep pressure in CFS+FM. In contrast, CFS alone has greater probabilities of 
transitions from REM sleep to awake than healthy controls, suggesting the lower sleep 
pressure in CFS alone. Finding such differences is support for the thesis that FM is different 
illness from CFS, associated with different problems in sleep regulation. 
6. Acknowledgment 
This work is supported, in part, by National Institute of Health Grant AI-54478 and by 
Grant-in-Aid for Scientific Research (C) (22500690). 
7. References 
Afari N. & Buchwald D. (2003). Chronic Fatigue Syndrome: a Review. The American Journal 
of Psychiatry, Vol.160, No.2, (February 2003), ISSN 0002-953X 
Affleck G.; Urrows S.; Tennen H.; Higgins P. & Abeles M. (1996). Sequential Daily Relations 
of Sleep, Pain Intensity, and Attention to Pain Among Women With Fibromyalgia. 
Pain, Vol.68, No.2-3, (December 1996), ISSN 0304-3959 
American Sleep Disorders Association. (1992). EEG Arousals: Scoring Rules and Examples: a 
Preliminary Report From the Sleep Disorders Atlas Task Force of the American 
Sleep Disorders Association. Sleep, Vol.15, No.2, (April 1992), ISSN 0161-8105 
Anch A.M.; Lue F.A.; MacLean A.W. & Moldofsky H. (1991). Sleep Physiology and 
Psychological Aspects of the Fibrositis (Fibromyalgia) Syndrome. Canadian Journal 
of Psychology, Vol.45, No.2, (June 1991), ISSN 0008-4255 
Arnold L.M.; Zlateva G.; Sadosky A.; Emir B. & Whalen E. (2011). Correlations Between 
Fibromyalgia Symptom and Function Domains and Patient Global Impression of 
Change: a Pooled Analysis of Three Randomized, Placebo-Controlled Trials of 
Pregabalin. Pain Medicine, Vol.12, No.2, (February 2011), ISSN 1526-2375 
Bannister K.; Bee L.A. & Dickenson A.H. (2009). Preclinical and Early Clinical Investigations 
Related to Monoaminergic Pain Modulation. Neurotherapeutics : The Journal of the 
American Society for Experimental NeuroTherapeutics, Vol.6, No.4, (October 2009), 
ISSN 1933-7213 
Bigatti S.M.; Hernandez A.M.; Cronan T.A. & Rand K.L. (2008). Sleep Disturbances in 
Fibromyalgia Syndrome: Relationship to Pain and Depression. Arthritis and 
Rheumatism, Vol.59, No.7, (July 2008), ISSN 0004-3591 
Branco J.; Atalaia A. & Paiva T. (1994). Sleep Cycles and Alpha-Delta Sleep in Fibromyalgia 
Syndrome. The Journal of Rheumatology, Vol.21, No.6, (June 1994), ISSN 0315-162X 
Buchwald D.; Pascualy R.; Bombardier C. & Kith P. (1994). Sleep Disorders in Patients With 
Chronic Fatigue. Clinical Infectious Diseases, Vol.18 Suppl 1, (January 1994), ISSN 
1058-4838 
www.intechopen.com
 
New Insights into Fibromyalgia 
 
12
Burns J.W.; Crofford L.J. & Chervin R.D. (2008). Sleep Stage Dynamics in Fibromyalgia 
Patients and Controls. Sleep Medicine, Vol.9, No.6, (August 2008), ISSN 1389-9457 
Carley D.W.; Applebaum R.; Basner R.C.; Onal E. & Lopata M. (1997). Respiratory and 
Arousal Responses to Acoustic Stimulation. Chest, Vol.112, No.6, (December 1997), 
ISSN 0012-3692 
Carskadon M.A. & Dement W.C. (1979). Effects of Total Sleep Loss on Sleep Tendency. 
Perceptual and Motor Skills, Vol.48, No.2, (April 1979), ISSN 0031-5125 
Chervin R.D.; Teodorescu M.; Kushwaha R.; Deline A.M.; Brucksch C.B.; Ribbens-Grimm C.; 
Ruzicka D.L.; Stein P.K.; Clauw D.J. & Crofford L.J. (2009). Objective Measures of 
Disordered Sleep in Fibromyalgia. The Journal of Rheumatology, Vol.36, No.9, 
(September 2009), ISSN 0315-162X 
Comte J.C.; Ravassard P. & Salin P.A. (2006). Sleep Dynamics: a Self-Organized Critical 
System. Physical Review E, Statistical, Nonlinear, and Soft Matter Physics, Vol.73, No.5 
Pt 2, (May 2006), ISSN 1539-3755 
Cote K.A. & Moldofsky H. (1997). Sleep, Daytime Symptoms, and Cognitive Performance in 
Patients With Fibromyalgia. The Journal of Rheumatology, Vol.24, No.10, (October 
1997), ISSN 0315-162X 
Cox D.R. (1972). Regression Models and Life-Tables. Journal of the Royal Statistical Society 
Series B (Methodological), Vol.34, No.2, (March 1972), ISSN 00359246 
De Gennaro L. & Ferrara M. (2003). Sleep Spindles: an Overview. Sleep Medicine Reviews, 
Vol.7, No.5, (October 2003), ISSN 1087-0792 
Devoto A.; Lucidi F.; Violani C. & Bertini M. (1999). Effects of Different Sleep Reductions on 
Daytime Sleepiness. Sleep, Vol.22, No.3, (May 1999), ISSN 0161-8105 
Drewes A.M.; Nielsen K.D.; Taagholt S.J.; Bjerregard K.; Svendsen L. & Gade J. (1995). Sleep 
Intensity in Fibromyalgia: Focus on the Microstructure of the Sleep Process. British 
Journal of Rheumatology, Vol.34, No.7, (July 1995), ISSN 0263-7103 
Drewes A.M.; Svendsen L.; Nielsen K.D.; Taagholt S.J. & Bjerregard K. (1994). Quantification 
of Alpha-EEG Activity During Sleep in Fibromyalgia: A Study Based on 
Ambulatory Sleep Monitoring. Journal of Musculoskeletal Pain, Vol.2, No.4, (1994), 
ISSN 1058-2452 
Fischler B. (1999). Review of Clinical and Psychobiological Dimensions of the Chronic 
Fatigue Syndrome: Differentiation From Depression and Contribution of Sleep 
Dysfunctions. Sleep Medicine Reviews, Vol.3, No.2, (June 1999), ISSN 1087-0792 
Fischler B.; Le Bon O.; Hoffmann G.; Cluydts R.; Kaufman L. & De Meirleir K. (1997). Sleep 
Anomalies in the Chronic Fatigue Syndrome. A Comorbidity Study. 
Neuropsychobiology, Vol.35, No.3, (1997), ISSN 0302-282X 
Gold A.R.; Dipalo F.; Gold M.S. & Broderick J. (2004). Inspiratory Airflow Dynamics During 
Sleep in Women With Fibromyalgia. Sleep, Vol.27, No.3, (May 2004), ISSN 0161-
8105 
Halasz P. (1993). Arousals Without Awakening--Dynamic Aspect of Sleep. Physiology & 
Behavior, Vol.54, No.4, (October 1993), ISSN 0031-9384 
Hobson J.A.; Lydic R. & Baghdoyan H.A. (1986). Evolving Concepts of Sleep Cycle 
Generation: From Brain Centers to Neuronal Populations. Behavioral and Brain 
Sciences, Vol.9, No.3, (1986), ISSN 0140-525X 
www.intechopen.com
 
Sleep and Fibromyalgia 
 
13 
Horne J.A. & Shackell B.S. (1991). Alpha-Like EEG Activity in Non-REM Sleep and  
the Fibromyalgia (Fibrositis) Syndrome. Electroencephalography and Clinical 
Neurophysiology, Vol.79, No.4, (October 1991), ISSN 0013-4694 
Horne J.A. & Staff L.H. (1983). Exercise and Sleep: Body-Heating Effects. Sleep, Vol.6, No.1, 
(1983), ISSN 0161-8105 
Jennum P.; Drewes A.M.; Andreasen A. & Nielsen K.D. (1993). Sleep and Other Symptoms 
in Primary Fibromyalgia and in Healthy Controls. The Journal of Rheumatology, 
Vol.20, No.10, (October 1993), ISSN 0315-162X 
Juhl J.H. (1998). Fibromyalgia and the Serotonin Pathway. Alternative Medicine Review : a 
Journal of Clinical Therapeutic, Vol.3, No.5, (October 1998), ISSN 1089-5159 
Kishi A.; Natelson B.H.; Togo F.; Struzik Z.R.; Rapoport D.M.& Yamamoto Y. (In press). 
Sleep-Stage Dynamics in Patients With Chronic Fatigue Syndrome With or Without 
Fibromyalgia. Sleep, (In press), 0161-8105 
Kishi A.; Struzik Z.R.; Natelson B.H.; Togo F. & Yamamoto Y. (2008). Dynamics of Sleep 
Stage Transitions in Healthy Humans and Patients With Chronic Fatigue 
Syndrome. American Journal of Physiology Regulatory, Integrative and Comparative 
Physiology, Vol.294, No.6, (June 2008), ISSN 0363-6119 
Kishi A.; Yasuda H.; Matsumoto T.; Inami Y.; Horiguchi J.; Struzik Z.R. & Yamamoto Y. 
(2010). Sleep Stage Transitions in Healthy Humans Altered by Central 
Monoaminergic Antagonist. Methods of Information in Medicine, Vol.49, No.5, (2010), 
ISSN 0026-1270 
Komaroff A.L. & Buchwald D. (1991). Symptoms and Signs of Chronic Fatigue Syndrome. 
Reviews of Infectious Diseases, Vol.13 Suppl 1, (January 1991), ISSN 0162-0886 
Korszun A.; Young E.A.; Engleberg N.C.; Brucksch C.B.; Greden J.F. & Crofford L.A. (2002). 
Use of Actigraphy for Monitoring Sleep and Activity Levels in Patients With 
Fibromyalgia and Depression. Journal of Psychosomatic Research, Vol.52, No.6, (June 
2002), ISSN 0022-3999 
Koyama Y. & Hayaishi O. (1994). Firing of Neurons in the Preoptic/Anterior Hypothalamic 
Areas in Rat: Its Possible Involvement in Slow Wave Sleep and Paradoxical Sleep. 
Neuroscience Research, Vol.19, No.1, (February 1994), ISSN 0168-0102 
Krupp L.B.; Jandorf L.; Coyle P.K. & Mendelson W.B. (1993). Sleep Disturbance in Chronic 
Fatigue Syndrome. Journal of Psychosomatic Research, Vol.37, No.4, (May 1993), ISSN 
0022-3999 
Landis C.A.; Lentz M.J.; Tsuji J.; Buchwald D. & Shaver J.L. (2004). Pain, Psychological 
Variables, Sleep Quality, and Natural Killer Cell Activity in Midlife Women With 
and Without Fibromyalgia. Brain, Behavior, and Immunity, Vol.18, No.4, (July 2004), 
ISSN 0889-1591 
Lange, G. & Natelson, B.H. (2009). Chronic Fatigue Syndrome, In: Functional Pain Syndromes: 
Presentation and Pathophysiology, 1st ed., E.A.Mayer, M.C.Bushnell, (Ed.), 245-261, 
IASP Press, ISBN 978-0931092756, Seattle, USA 
Lashley F.R. (2003). A Review of Sleep in Selected Immune and Autoimmune Disorders. 
Holistic Nursing Practice, Vol.17, No.2, (March 2003), ISSN 0887-9311 
www.intechopen.com
 
New Insights into Fibromyalgia 
 
14
Le Bon O.; Fischler B.; Hoffmann G.; Murphy J.R.; De Meirleir K.; Cluydts R. & Pelc I. (2000). 
How Significant Are Primary Sleep Disorders and Sleepiness in the Chronic 
Fatigue Syndrome? Sleep Research Online : SRO, Vol.3, No.2, (2000), ISSN 1096-214X 
Lentz M.J.; Landis C.A.; Rothermel J. & Shaver J.L. (1999). Effects of Selective Slow Wave 
Sleep Disruption on Musculoskeletal Pain and Fatigue in Middle Aged Women. 
The Journal of Rheumatology, Vol.26, No.7, (July 1999), ISSN 0315-162X 
Leventhal L.; Freundlich B.; Lewis J.; Gillen K.; Henry J. & Dinges D. (1995). Controlled 
Study of Sleep Parameters in Patients With Fibromyalgia. Journal of Clinical 
Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases, Vol.1, No.2, 
(April 1995), ISSN 1076-1608 
Lo C.C.; Amaral L.A.N.; Havlin S.; Ivanov P.C.; Penzel T.; Peter J.H. & Stanley H.E. (2002). 
Dynamics of Sleep-Wake Transitions During Sleep. Europhysics Letters, Vol.57, 
No.5, (March 2002), ISSN 0295-5075 
Lo C.C.; Chou T.; Penzel T.; Scammell T.E.; Strecker R.E.; Stanley H.E. & Ivanov P.C. (2004). 
Common Scale-Invariant Patterns of Sleep-Wake Transitions Across Mammalian 
Species. Proceedings of the National Academy of Sciences of the United States of America, 
Vol.101, No.50, (December 2004), ISSN 0027-8424 
Martin S.E.; Engleman H.M.; Deary I.J. & Douglas N.J. (1996). The Effect of Sleep 
Fragmentation on Daytime Function. American Journal of Respiratory and Critical Care 
Medicine, Vol.153, No.4 Pt 1, (April 1996), ISSN 1073-449X 
Martin S.E.; Engleman H.M.; Kingshott R.N. & Douglas N.J. (1997). Microarousals in 
Patients With Sleep Apnoea/Hypopnoea Syndrome. Journal of Sleep Research, Vol.6, 
No.4, (December 1997), ISSN 0962-1105 
McCarley R.W. (2007). Neurobiology of REM and NREM Sleep. Sleep Medicine, Vol.8, No.4, 
(June 2007), ISSN 1389-9457 
McNamara M.E. (1993). Alpha Sleep: a Mini Review and Update. Clinical EEG 
(Electroencephalography), Vol.24, No.4, (October 1993), ISSN 0009-9155 
Moldofsky H. (1989). Sleep and Fibrositis Syndrome. Rheumatic Diseases Clinics of North 
America, Vol.15, No.1, (February 1989), ISSN 0889-857X 
Moldofsky H. (2002). Management of Sleep Disorders in Fibromyalgia. Rheumatic Diseases 
Clinics of North America, Vol.28, No.2, (May 2002), ISSN 0889-857X 
Moldofsky H. (2008). The Significance of the Sleeping-Waking Brain for the Understanding 
of Widespread Musculoskeletal Pain and Fatigue in Fibromyalgia Syndrome and 
Allied Syndromes. Joint, Bone, Spine : Revue du Rhumatisme, Vol.75, No.4, (July 
2008), ISSN 1297-319X 
Moldofsky H.; Lue F.A. & Smythe H.A. (1983). Alpha EEG Sleep and Morning Symptoms in 
Rheumatoid Arthritis. The Journal of Rheumatology, Vol.10, No.3, (June 1983), ISSN 
0315-162X 
Moldofsky H.; Saskin P. & Lue F.A. (1988). Sleep and Symptoms in Fibrositis Syndrome 
After a Febrile Illness. The Journal of Rheumatology, Vol.15, No.11, (November 1988), 
ISSN 0315-162X 
Moldofsky H. & Scarisbrick P. (1976). Induction of Neurasthenic Musculoskeletal Pain 
Syndrome by Selective Sleep Stage Deprivation. Psychosomatic Medicine, Vol.38, 
No.1, (January 1976), ISSN 0033-3174 
www.intechopen.com
 
Sleep and Fibromyalgia 
 
15 
Moldofsky H.; Scarisbrick P.; England R. & Smythe H. (1975). Musculosketal Symptoms and 
Non-REM Sleep Disturbance in Patients With "Fibrositis Syndrome" and Healthy 
Subjects. Psychosomatic Medicine, Vol.37, No.4, (July 1975), ISSN 0033-3174 
Molony R.R.; MacPeek D.M.; Schiffman P.L.; Frank M.; Neubauer J.A.; Schwartzberg M. & 
Seibold J.R. (1986). Sleep, Sleep Apnea and the Fibromyalgia Syndrome. The Journal 
of Rheumatology, Vol.13, No.4, (August 1986), ISSN 0315-162X 
Morriss R.; Sharpe M.; Sharpley A.L.; Cowen P.J.; Hawton K. & Morris J. (1993). 
Abnormalities of Sleep in Patients With the Chronic Fatigue Syndrome. British 
Medical Journal, Vol.306, No.6886, (May 1993), ISSN 0959-8138 
Nakamura T.; Togo F.; Cherniack N.S.; Rapoport D.M. & Natelson B.H. (2010). A Subgroup 
of Patietns With Chronic Fatigue Syndrome May Have a Disorder of Arousal. The 
Open Sleep Journal No.3, (2010), ISSN 1874-6209 
Neeck G. & Riedel W. (1994). Neuromediator and Hormonal Perturbations in Fibromyalgia 
Syndrome: Results of Chronic Stress? Bailliere's Clinical Rheumatology, Vol.8, No.4, 
(November 1994), ISSN 0950-3579 
O'Brien E.M.; Waxenberg L.B.; Atchison J.W.; Gremillion H.A.; Staud R.M.; McCrae C.S. & 
Robinson M.E. (2011). Intraindividual Variability in Daily Sleep and Pain Ratings 
Among Chronic Pain Patients: Bidirectional Association and the Role of Negative 
Mood. The Clinical Journal of Pain, Vol.27, No.5, (June 2011), ISSN 0749-8047 
O'Brien E.M.; Waxenberg L.B.; Atchison J.W.; Gremillion H.A.; Staud R.M.; McCrae C.S. & 
Robinson M.E. (2010). Negative Mood Mediates the Effect of Poor Sleep on Pain 
Among Chronic Pain Patients. The Clinical Journal of Pain, Vol.26, No.4, (May 2010), 
ISSN 0749-8047 
Older S.A.; Battafarano D.F.; Danning C.L.; Ward J.A.; Grady E.P.; Derman S. & Russell I.J. 
(1998). The Effects of Delta Wave Sleep Interruption on Pain Thresholds and 
Fibromyalgia-Like Symptoms in Healthy Subjects; Correlations With Insulin-Like 
Growth Factor I. The Journal of Rheumatology, Vol.25, No.6, (June 1998), ISSN 0315-
162X 
Onen S.H.; Alloui A.; Gross A.; Eschallier A. & Dubray C. (2001). The Effects of Total Sleep 
Deprivation, Selective Sleep Interruption and Sleep Recovery on Pain Tolerance 
Thresholds in Healthy Subjects. Journal of Sleep Research, Vol.10, No.1, (March 2001), 
ISSN 0962-1105 
Perlis M.L.; Giles D.E.; Bootzin R.R.; Dikman Z.V.; Fleming G.M.; Drummond S.P. & Rose 
M.W. (1997). Alpha Sleep and Information Processing, Perception of Sleep, Pain, 
and Arousability in Fibromyalgia. The International Journal of Neuroscience, Vol.89, 
No.3-4, (February 1997), ISSN 0020-7454 
Pitson D.J. & Stradling J.R. (1998). Autonomic Markers of Arousal During Sleep in Patients 
Undergoing Investigation for Obstructive Sleep Apnoea, Their Relationship to EEG 
Arousals, Respiratory Events and Subjective Sleepiness. Journal of Sleep Research, 
Vol.7, No.1, (March 1998), ISSN 0962-1105 
Rechtstchaffen A. & Kales A. (1968). A Manual of Standardized Terminology, Techniques and 
Scoring System for Sleep States of Human Subjects. US Government Printing Office, 
National Institute of Health Publication, Washington (DC), USA 
www.intechopen.com
 
New Insights into Fibromyalgia 
 
16
Reeves W.C.; Heim C.; Maloney E.M.; Youngblood L.S.; Unger E.R.; Decker M.J.; Jones J.F. & 
Rye D.B. (2006). Sleep Characteristics of Persons With Chronic Fatigue Syndrome 
and Non-Fatigued Controls: Results From a Population-Based Study. BMC 
Neurology, Vol.6, (2006), ISSN 1471-2377 
Rizzi M.; Sarzi-Puttini P.; Atzeni F.; Capsoni F.; Andreoli A.; Pecis M.; Colombo S.; Carrabba 
M. & Sergi M. (2004). Cyclic Alternating Pattern: a New Marker of Sleep Alteration 
in Patients With Fibromyalgia? The Journal of Rheumatology, Vol.31, No.6, (June 
2004), ISSN 0315-162X 
Roizenblatt S.; Moldofsky H.; edito-Silva A.A. & Tufik S. (2001). Alpha Sleep Characteristics 
in Fibromyalgia. Arthritis and Rheumatism, Vol.44, No.1, (January 2001), ISSN 0004-
3591 
Scheuler W.; Stinshoff D. & Kubicki S. (1983). The Alpha-Sleep Pattern. Differentiation From 
Other Sleep Patterns and Effect of Hypnotics. Neuropsychobiology, Vol.10, No.2-3, 
(1983), ISSN 0302-282X 
Sethna J.P.; Dahmen K.A. & Myers C.R. (2001). Crackling Noise. Nature, Vol.410, No.6825, 
(March 2001), ISSN 0028-0836 
Sforza E.; Jouny C. & Ibanez V. (2000). Cardiac Activation During Arousal in Humans: 
Further Evidence for Hierarchy in the Arousal Response. Clinical Neurophysiology, 
Vol.111, No.9, (September 2000), ISSN 1388-2457 
Sforza E.; Juony C. & Ibanez V. (2002). Time-Dependent Variation in Cerebral and 
Autonomic Activity During Periodic Leg Movements in Sleep: Implications for 
Arousal Mechanisms. Clinical Neurophysiology, Vol.113, No.6, (June 2002), ISSN 
1388-2457 
Sharpley A.; Clements A.; Hawton K. & Sharpe M. (1997). Do Patients With "Pure" Chronic 
Fatigue Syndrome (Neurasthenia) Have Abnormal Sleep? Psychosomatic Medicine, 
Vol.59, No.6, (November 1997), ISSN 0033-3174 
Shaver J.L.; Lentz M.; Landis C.A.; Heitkemper M.M.; Buchwald D.S. & Woods N.F. (1997). 
Sleep, Psychological Distress, and Stress Arousal in Women With Fibromyalgia. 
Research in Nursing & Health, Vol.20, No.3, (June 1997), ISSN 0160-6891 
Sisto S.A.; LaManca J.; Cordero D.L.; Bergen M.T.; Ellis S.P.; Drastal S.; Boda W.L.; Tapp 
W.N. & Natelson B.H. (1996). Metabolic and Cardiovascular Effects of a 
Progressive Exercise Test in Patients With Chronic Fatigue Syndrome. The American 
Journal of Medicine, Vol.100, No.6, (June 1996), ISSN 0002-9343 
Sisto S.A.; Tapp W.N.; LaManca J.J.; Ling W.; Korn L.R.; Nelson A.J. & Natelson B.H. (1998). 
Physical Activity Before and After Exercise in Women With Chronic Fatigue 
Syndrome. QJM : Monthly Journal of the Association of Physicians, Vol.91, No.7, (July 
1998), ISSN 1460-2725 
Sornette D. (2004). Critical Phenomena in Natural Sciences: Chaos, Fractals, Self-Organization and 
Disorder: Concepts and Tools. 2nd ed. Springer, ISBN 978-3540308829, Berlin, 
Germany 
Spitzer A.R. & Broadman M. (2010). A Retrospective Review of the Sleep Characteristics in 
Patients With Chronic Fatigue Syndrome and Fibromyalgia. Pain Practice, Vol.10, 
No.4, (July 2010), ISSN 1530-7085 
www.intechopen.com
 
Sleep and Fibromyalgia 
 
17 
Terzano M.G. & Parrino L. (2000). Origin and Significance of the Cyclic Alternating Pattern 
(CAP). REVIEW ARTICLE. Sleep Medicine Reviews, Vol.4, No.1, (February 2000), 
ISSN 1087-0792 
Theadom A.; Cropley M. & Humphrey K.L. (2007). Exploring the Role of Sleep and Coping 
in Quality of Life in Fibromyalgia. Journal of Psychosomatic Research, Vol.62, No.2, 
(February 2007), ISSN 0022-3999 
Togo F.; Cherniack N.S. & Natelson B.H. (2006). Electroencephalogram Characteristics of 
Autonomic Arousals During Sleep in Healthy Men. Clinical Neurophysiology, 
Vol.117, No.12, (December 2006), ISSN 1388-2457 
Togo F.; Natelson B.H.; Cherniack N.S.; FitzGibbons J.; Garcon C. & Rapoport D.M. (2008). 
Sleep Structure and Sleepiness in Chronic Fatigue Syndrome With or Without 
Coexisting Fibromyalgia. Arthritis Research & Therapy, Vol.10, No.3, (2008), ISSN 
1478-6362 
Togo F.; Natelson B.H.; Cherniack N.S.; Klapholz M.; Rapoport D.M. & Cook D.B. (2010). 
Sleep Is Not Disrupted by Exercise in Patients With Chronic Fatigue Syndromes. 
Medicine and Science in Sports and Exercise, Vol.42, No.1, (January 2010), ISSN 0195-
9131 
Unger E.R.; Nisenbaum R.; Moldofsky H.; Cesta A.; Sammut C.; Reyes M. & Reeves W.C. 
(2004). Sleep Assessment in a Population-Based Study of Chronic Fatigue 
Syndrome. BMC Neurology, Vol.4, (April 2004), ISSN 1471-2377 
Van Hoof E.; De Becker P.; Lapp C.; Cluydts R. & De Meirleir K. (2007). Defining the 
Occurrence and Influence of Alpha-Delta Sleep in Chronic Fatigue Syndrome. The 
American Journal of the Medical Sciences, Vol.333, No.2, (February 2007), ISSN 0002-
9629 
Viola-Saltzman M.; Watson N.F.; Bogart A.; Goldberg J. & Buchwald D. (2010). High 
Prevalence of Restless Legs Syndrome Among Patients With Fibromyalgia: a 
Controlled Cross-Sectional Study. Journal of Clinical Sleep Medicine, Vol.6, No.5, 
(October 2010), ISSN 1550-9389 
Weaver S.A.; Janal M.N.; Aktan N.; Ottenweller J.E. & Natelson B.H. (2010). Sex Differences 
in Plasma Prolactin Response to Tryptophan in Chronic Fatigue Syndrome Patients 
With and Without Comorbid Fibromyalgia. Journal of Women's Health, Vol.19, No.5, 
(May 2010), ISSN 1059-7115 
White K.P.; Speechley M.; Harth M. & Ostbye T. (1999). The London Fibromyalgia 
Epidemiology Study: Comparing the Demographic and Clinical Characteristics in 
100 Random Community Cases of Fibromyalgia Versus Controls. The Journal of 
Rheumatology, Vol.26, No.7, (July 1999), ISSN 0315-162X 
Winkelman J.W. (1999). The Evoked Heart Rate Response to Periodic Leg Movements of 
Sleep. Sleep, Vol.22, No.5, (August 1999), ISSN 0161-8105 
Wolfe F.; Smythe H.A.; Yunus M.B.; Bennett R.M.; Bombardier C.; Goldenberg D.L.; Tugwell 
P.; Campbell S.M.; Abeles M.; Clark P. et al. (1990). The American College of 
Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the 
Multicenter Criteria Committee. Arthritis and Rheumatism, Vol.33, No.2, (February 
1990), ISSN 0004-3591 
www.intechopen.com
 
New Insights into Fibromyalgia 
 
18
Yassouridis A.; Steiger A.; Klinger A. & Fahrmeir L. (1999). Modelling and Exploring 
Human Sleep With Event History Analysis. Journal of Sleep Research, Vol.8, No.1, 
(March 1999), ISSN 0962-1105 
Yoshiuchi K.; Cook D.B.; Ohashi K.; Kumano H.; Kuboki T.; Yamamoto Y. & Natelson B.H. 
(2007). A Real-Time Assessment of the Effect of Exercise in Chronic Fatigue 
Syndrome. Physiology & Behavior, Vol.92, No.5, (December 2007), ISSN 0031-9384 
Youngstedt S.D.; O'Connor P.J. & Dishman R.K. (1997). The Effects of Acute Exercise on 
Sleep: a Quantitative Synthesis. Sleep, Vol.20, No.3, (March 1997), ISSN 0161-8105 
www.intechopen.com
New Insights into Fibromyalgia
Edited by Dr. William S. Wilke
ISBN 978-953-307-407-8
Hard cover, 216 pages
Publisher InTech
Published online 05, January, 2012
Published in print edition January, 2012
InTech Europe
University Campus STeP Ri 
Slavka Krautzeka 83/A 
51000 Rijeka, Croatia 
Phone: +385 (51) 770 447 
Fax: +385 (51) 686 166
www.intechopen.com
InTech China
Unit 405, Office Block, Hotel Equatorial Shanghai 
No.65, Yan An Road (West), Shanghai, 200040, China 
Phone: +86-21-62489820 
Fax: +86-21-62489821
Given the potential problems that can obscure any scientific enterprise, inconsistent results across studies are
bound to occur. How are we to decide what is true? Let's turn to philosophy for a reasonable answer. The
mathematician-philosopher Bertrand Russell approached a similar problem in his monograph The Problems of
Philosophy (Russell B, 1912). He addressed the following question: How do we know that anything is "real"? Is
the only reality subjective and simply in our minds, as Bishop Berkley challenged, or can we mostly believe the
objective reality? His pragmatic answer: All possibilities may be true, but when the preponderance of evidence
indicates that objective reality and knowledge are the most probable case, go with it. If the preponderance of
all evidence about the clinical description of fibromyalgia and it's pathogenic mechanisms and treatment
strategies indicate a highly probable interrelated hypothesis, go with it. The direction of the literature on the
whole trumps the less likely tangents. At the same time, remember Bertrand Russell and his pragmatic
answer, and keep an open mind.
How to reference
In order to correctly reference this scholarly work, feel free to copy and paste the following:
Fumiharu Togo, Akifumi Kishi and Benjamin H. Natelson (2012). Sleep and Fibromyalgia, New Insights into
Fibromyalgia, Dr. William S. Wilke (Ed.), ISBN: 978-953-307-407-8, InTech, Available from:
http://www.intechopen.com/books/new-insights-into-fibromyalgia/sleep-and-fibromyalgia
© 2012 The Author(s). Licensee IntechOpen. This is an open access article
distributed under the terms of the Creative Commons Attribution 3.0
License, which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
